Science T-CURX Secures $20 Million to Revolutionize CAR-T Cancer Therapies T-CURX GmbH, a biotechnology start-up based in Würzburg, has successfully secured $20 million in its initial financing round. This investment, led by the Swiss... Editorial17 December, 2025